Plasma leptin correlates with anthranilic acid in schizophrenia but not in major depressive disorder

被引：3
|
作者：
Steiner, J. [1 ]
Bernstein, H. -G. [1 ]
Guest, P. C. [2 ]
Summergrad, P. [3 ]
Oxenkrug, G. [4 ]
机构：
[1] Univ Magdeburg, Dept Psychiat, Magdeburg, Germany
[2] Univ Campinas UNICAMP, Dept Biochem & Tissue Biol, Lab Neuroprote, Campinas, Brazil
[3] Tufts Univ, Sch Med, Dept Psychiat, Tufts Med Ctr, Boston, MA 02111 USA
[4] Tufts Univ, Sch Med, Psychiat & Inflammat Program, Tufts Med Ctr, Boston, MA 02111 USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2020年 / 41卷
关键词：
D O I：
10.1016/j.euroneuro.2020.08.001
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：167 / 168
页数：2
相关论文
共 50 条
  • [31] Striatal Excitatory Amino Acid Transporter Transcript Expression in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
    Robert E McCullumsmith
    James H Meador-Woodruff
    Neuropsychopharmacology, 2002, 26 : 368 - 375
  • [32] Effects of Schizophrenia and Major Depressive Disorder on Subcortical Morphometry
    Gutman, Boris A.
    Hatton, Sean
    Alpert, Kathryn
    Kelly, Sinead
    Schmaal, Lianne
    Veltman, Dick
    Wang, Lei
    Thompson, Paul
    BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 168S - 169S
  • [33] A comparison of psychotic phenomena in bipolar disorder, major depressive disorder and schizophrenia
    Toh, W. L.
    Thomas, N.
    Rossell, S.
    BIPOLAR DISORDERS, 2016, 18 : 119 - 119
  • [34] Intelligence decline across major depressive disorder, bipolar disorder, and schizophrenia
    Ohi, Kazutaka
    Takai, Kentaro
    Sugiyama, Shunsuke
    Kitagawa, Hiromi
    Kataoka, Yuzuru
    Soda, Midori
    Kitaichi, Kiyoyuki
    Kawasaki, Yasuhiro
    Ito, Munechika
    Shioiri, Toshiki
    CNS SPECTRUMS, 2022, 27 (04) : 468 - 474
  • [35] Plasma Nervonic Acid Is a Potential Biomarker for Major Depressive Disorder: A Pilot Study
    Kageyama, Yuki
    Kasahara, Takaoki
    Nakamura, Takemichi
    Hattori, Kotaro
    Deguchi, Yasuhiko
    Tani, Munehide
    Kuroda, Kenji
    Yoshida, Sumiko
    Goto, Yu-ichi
    Inoue, Koki
    Kato, Tadafumi
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2018, 21 (03): : 207 - 215
  • [36] Molecular genetic overlap in bipolar disorder, schizophrenia, and major depressive disorder
    Schulze, Thomas G.
    Akula, Nirmala
    Breuer, Rene
    Steele, Jo
    Nalls, Michael A.
    Singleton, Andrew B.
    Degenhardt, Franziska A.
    Noethen, Markus M.
    Cichon, Sven
    Rietschel, Marcella
    Mcmahon, Francis J.
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2014, 15 (03): : 200 - 208
  • [37] Reduced Cerebrospinal Fluid Levels of Lysophosphatidic Acid Docosahexaenoic Acid in Patients With Major Depressive Disorder and Schizophrenia
    Omori, Wataru
    Kano, Kuniyuki
    Hattori, Kotaro
    Kajitani, Naoto
    Okada-Tsuchioka, Mami
    Boku, Shuken
    Kunugi, Hiroshi
    Aoki, Junken
    Takebayashi, Minoru
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2021, 24 (12): : 948 - 955
  • [38] Plasma biomarkers to diagnose major depressive disorder
    Ohashi, Y.
    Shinoda, K.
    Sato, H.
    Ishikawa, T.
    Kawamura, N.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2010, 14 : 31 - 31
  • [39] Plasma and cerebrospinal fluid G72 protein levels in schizophrenia and major depressive disorder
    Ishiwata, Sayuri
    Hattori, Kotaro
    Sasayama, Daimei
    Teraishi, Toshiya
    Miyakawa, Tomoko
    Yokota, Yuuki
    Matsumura, Ryo
    Yoshida, Fuyuko
    Nishikawa, Tom
    Kunugi, Hiroshi
    PSYCHIATRY RESEARCH, 2017, 254 : 244 - 250
  • [40] A comparison of depressive symptom profiles between current major depressive disorder and schizophrenia spectrum disorder
    Lange, Sjors M. M.
    Schirmbeck, Frederike
    Stek, Max L.
    Jansen, Yentl R. Murk
    Rooijen, Geeske van
    Haan, Lieuwe de
    Penninx, Brenda W. J. H.
    Rhebergen, Didi
    JOURNAL OF PSYCHIATRIC RESEARCH, 2021, 135 : 143 - 151
12345